|Bid||0.00 x 900|
|Ask||0.00 x 800|
|Day's Range||87.86 - 89.79|
|52 Week Range||54.55 - 102.89|
|PE Ratio (TTM)||N/A|
|Earnings Date||Oct 31, 2018 - Nov 5, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||101.43|
Insulet Corporation , the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System , today announced it will showcase its recently FDA cleared Omnipod DASH™ Insulin Management System , during the American Association of Diabetes Educators meeting at the Baltimore Convention Center in Baltimore, Maryland on August 17-20, 2018.
We are encouraged by the year-over-year improvement in Insulet's (PODD) results on solid uptake of Omnipod system in the United States in Q2.
The tubeless insulin pump specialist's revenue growth slowed notably in the second quarter, but management said this is a short-term phenomenon related to the company's transition to a direct sales model in Europe.
Insulet (PODD) delivered earnings and revenue surprises of 76.92% and -6.52%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Billerica, Massachusetts-based company said it had a loss of 3 cents. The results beat Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment ...
Full Year 2018 Expected Revenue Growth Revised to 18% to 21%
NEW YORK, NY / ACCESSWIRE / August 2, 2018 / Insulet Corporation (NASDAQ: PODD ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 2, 2018 at 4:30 PM Eastern Time. ...
Don't be caught off-guard: Insulet (NASDAQ: PODD ) releases its next round of earnings Thursday. Want to skip the homework and get all the facts in one place? We thought so. Here is your everything-that-matters ...
Hill-Rom (HRC) registers a solid year-over-year revenue rise on strong domestic growth, driven by a robust performance at Patient Support Systems and Surgical Solutions.
The improvement within Zimmer Biomet's (ZBH) global Knee and Hip sales performance and ongoing growth within the Asia Pacific region are encouraging.
Though GNC Holdings' (GNC) domestic retail comps are slightly weaker than expected, the company performs strongly in e-commerce business and at International segment.
Thermo Fisher (TMO) is performing well on the back of a series of product launches along with major progress in precision medicine initiatives.
Quest Diagnostics (DGX) gains on successful execution of its two-point strategy of accelerating growth and driving operational excellence in Q2.
This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on July 19. Over the last one-month, outflows of investor capital in ETFs holding PODD totaled $1.24 billion.
Under assessment this morning are these four equities: Myomo Inc. (NYSE AMER: MYO), Neovasc Inc. (NASDAQ: NVCN), Smith & Nephew PLC (NYSE: SNN), and Insulet Corp. (NASDAQ: PODD). All you have to do is sign up today for this free limited time offer by clicking the link below.
Insulet Corporation (PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced that it has partnered with Glooko®, Inc. to connect Insulet’s Omnipod System user data with Glooko+diasend®, the most comprehensive diabetes data management system available, across Europe.
Insulet Corporation (PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced plans to release its financial results for the second quarter of 2018 on August 2, 2018 after the close of the financial markets. The link to the live call will be available on the Investor Relations section of the Company's website at http://investors.insulet.com, “Events and Presentations”, and will be archived for future replay. You may also access the live call by dialing (844) 831-3022 for domestic callers or (315) 625-6887 for international callers, passcode is 3342069.